Breaking News, Financial News

Financial Report: GlaxoSmithKline

Revenues fall flat in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GlaxoSmithKline   2Q Revenues: $10.1 billion (flat) 2Q Earnings: $2.0 billion (-18%) YTD Revenues: $19.9 billion (-3%) YTD Earnings: $5.9 billion (-22%) Comments: Pharmaceuticals and Vaccines sales were up 5% in the quarter to $8.1 billion. Respiratory sales were up 8% to $1.4 billion, driven by Advair (+8%), Flovent (+12%) and Ventolin (+18%). Oncology growth was driven by Votrient up 70% to $54.8 million, and Promacta up 38% to $28.9 million. Vaccine sales were up 14% driven by Infanrix/Pe...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters